J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 77 (1996), 1577-1583; DOI 10.1099/0022-1317-77-7-1577
© 1996 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gaukroger, J. M.
Right arrow Articles by Campo, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaukroger, J. M.
Right arrow Articles by Campo, M. S.
Agricola
Right arrow Articles by Gaukroger, J. M.
Right arrow Articles by Campo, M. S.

Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies

J. M. Gaukroger1, L. M. Chandrachud1, B. W. O'Neil1, G. J. Grindlay2, G. Knowles2 and M. S. Campo2

1 Department of Veterinary Pathology
and2 the Beatson Institute for Cancer Research, Garscube Estate, Glasgow G61 1BD, UK

Prophylactic vaccination of cattle with the N terminus (L2a, aa 11–200) of the minor capsid protein L2 completely prevented bovine papillomavirus type 4 (BPV-4) infection of the alimentary canal. To investigate the mechanisms underlying protection from viral infection, sera from vaccinated animals were analysed in neutralization assays both in the nude mouse xenograft system and in cattle. BPV-4 retained its infectivity when incubated with pre-immune cattle sera, whereas, when incubated with immune sera from animals vaccinated with either whole L2 or its N terminus L2a, its infectivity was greatly reduced, indicating that the immune sera had neutralizing activity against the virus. This activity could be abrogated by absorbing the immune sera with L2 or L2a, thus indicating that virus neutralization was due to the presence in the immune sera of anti-L2 antibodies.

Received 25 January 1996; accepted 1 March 1996.


This article has been cited by other articles:


Home page
J. Virol.Home page
R. Gambhira, B. Karanam, S. Jagu, J. N. Roberts, C. B. Buck, I. Bossis, H. Alphs, T. Culp, N. D. Christensen, and R. B. S. Roden
A Protective and Broadly Cross-Neutralizing Epitope of Human Papillomavirus L2
J. Virol., December 15, 2007; 81(24): 13927 - 13931.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Gambhira, S. Jagu, B. Karanam, P. E. Gravitt, T. D. Culp, N. D. Christensen, and R. B. S. Roden
Protection of Rabbits against Challenge with Rabbit Papillomaviruses by Immunization with the N Terminus of Human Papillomavirus Type 16 Minor Capsid Antigen L2
J. Virol., November 1, 2007; 81(21): 11585 - 11592.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. Laniosz, K. C. Nguyen, and P. I. Meneses
Bovine Papillomavirus Type 1 Infection Is Mediated by SNARE Syntaxin 18
J. Virol., July 15, 2007; 81(14): 7435 - 7448.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
A. Pawellek, G. Hewlett, J. Kreuter, H. Rübsamen-Waigmann, and O. Weber
Xenograft Model for Identifying Chemotherapeutic Agents against Papillomaviruses
Antimicrob. Agents Chemother., April 1, 2001; 45(4): 1014 - 1021.
[Abstract] [Full Text]


Home page
J. Virol.Home page
Y. Kawana, K. Kawana, H. Yoshikawa, Y. Taketani, K. Yoshiike, and T. Kanda
Human Papillomavirus Type 16 Minor Capsid Protein L2 N-Terminal Region Containing a Common Neutralization Epitope Binds to the Cell Surface and Enters the Cytoplasm
J. Virol., March 1, 2001; 75(5): 2331 - 2336.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
G. Sibbet, C. Romero-Graillet, G. Meneguzzi, and M. S. Campo
{alpha}6 integrin is not the obligatory cell receptor for bovine papillomavirus type 4
J. Gen. Virol., February 1, 2000; 81(2): 327 - 334.
[Abstract] [Full Text]


Home page
J. Virol.Home page
R. Han, N. M. Cladel, C. A. Reed, X. Peng, and N. D. Christensen
Protection of Rabbits from Viral Challenge by Gene Gun-Based Intracutaneous Vaccination with a Combination of Cottontail Rabbit Papillomavirus E1, E2, E6, and E7 Genes
J. Virol., August 1, 1999; 73(8): 7039 - 7043.
[Abstract] [Full Text]


Home page
J. Virol.Home page
K. Kawana, H. Yoshikawa, Y. Taketani, K. Yoshiike, and T. Kanda
Common Neutralization Epitope in Minor Capsid Protein L2 of Human Papillomavirus Types 16 and 6
J. Virol., July 1, 1999; 73(7): 6188 - 6190.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1996 by the Society for General Microbiology.